These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 12781064
1. Coagulation and fibrinolytic activity in patients with acute cerebral infarction. Li F, Zhang G, Zhao W. Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064 [Abstract] [Full Text] [Related]
2. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism]. Pang BS, Wang C, Lu Y, Yang YH, Xing GH, Mao YL, Huang XX, Zhai ZG. Zhonghua Yi Xue Za Zhi; 2007 Nov 20; 87(43):3074-8. PubMed ID: 18261355 [Abstract] [Full Text] [Related]
3. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C. Thromb Haemost; 1999 Feb 20; 81(2):275-80. PubMed ID: 10064006 [Abstract] [Full Text] [Related]
4. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Itakura H, Sobel BE, Boothroyd D, Leung LL, Iribarren C, Go AS, Fortmann SP, Quertermous T, Hlatky MA, Atherosclerotic Disease, Vascular Function and Genetic Epidemiology Advance (ADVANCE) Study. Am Heart J; 2007 Dec 20; 154(6):1059-64. PubMed ID: 18035075 [Abstract] [Full Text] [Related]
5. Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase. Jin L, Jin H, Zhang G, Xu G. Clin Hemorheol Microcirc; 2000 Dec 20; 23(2-4):213-8. PubMed ID: 11321442 [Abstract] [Full Text] [Related]
6. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC. Thromb Res; 2008 Dec 20; 121(5):675-80. PubMed ID: 17870147 [Abstract] [Full Text] [Related]
7. [Changes in the fibrinolytic activity in hypertension and acute cerebral infarction]. Guan KJ. Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun 20; 21(3):150-2, 186-7. PubMed ID: 8243228 [Abstract] [Full Text] [Related]
8. [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis]. Matsuura R, Soma M, Maeda Y, Kasakura S. Rinsho Byori; 1995 Dec 20; 43(12):1256-60. PubMed ID: 8569037 [Abstract] [Full Text] [Related]
9. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W. Med Sci Monit; 2000 Dec 20; 6(4):684-91. PubMed ID: 11208392 [Abstract] [Full Text] [Related]
10. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction. Mansfield MW, Catto AJ, Carter AM, Grant PJ. Diabet Med; 1998 Nov 20; 15(11):953-7. PubMed ID: 9827850 [Abstract] [Full Text] [Related]
11. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Agren A, Wiman B, Schulman S. Blood Coagul Fibrinolysis; 2007 Oct 20; 18(7):657-60. PubMed ID: 17890953 [Abstract] [Full Text] [Related]
12. [Value of coagulation function and fibrinolytic system assessment in patients with gestational diabetes mellitus]. Liu BY, Jian YL, Zhong M, Yu YH, Wang Q, Zhang J. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan 20; 27(1):35-7. PubMed ID: 17259140 [Abstract] [Full Text] [Related]
13. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus. Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T. Arthritis Rheum; 2009 Jul 20; 60(7):2094-101. PubMed ID: 19565516 [Abstract] [Full Text] [Related]
14. Altered endothelial function following the Fontan procedure. Binotto MA, Maeda NY, Lopes AA. Cardiol Young; 2008 Feb 20; 18(1):70-4. PubMed ID: 18093358 [Abstract] [Full Text] [Related]
15. Fibrinolysis system in patients with bronchial asthma. Banach-Wawrzeńczyk E, Dziedziczko A, Rość D. Med Sci Monit; 2000 Feb 20; 6(1):103-7. PubMed ID: 11208294 [Abstract] [Full Text] [Related]
16. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy]. Zalewska-Rydzkowska D, Rość D, Ponikowska I, Michalski A, Graczykowska-Koczorowska A, Rydzkowski M. Pol Merkur Lekarski; 2001 Nov 20; 11(65):414-7. PubMed ID: 11852811 [Abstract] [Full Text] [Related]
17. Prospective double-arm study of fibrinolysis in surgical patients. Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish LK, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan NP, Kozol RA. J Surg Res; 1998 Jan 20; 74(1):96-101. PubMed ID: 9536981 [Abstract] [Full Text] [Related]
18. [Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism]. Peng K, Wang C, Pang BS, Yang YH. Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep 20; 28(9):596-9. PubMed ID: 16207425 [Abstract] [Full Text] [Related]
19. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases. Collatos C, Barton MH, Prasse KW, Moore JN. J Am Vet Med Assoc; 1995 Aug 15; 207(4):465-70. PubMed ID: 7591947 [Abstract] [Full Text] [Related]
20. [Activation of fibrynolysis in children with chronic B or C hepatitis]. Michalska K, Szaflarska-Popławska A, Dymek G, Kotschy M. Pol Merkur Lekarski; 2004 Oct 15; 17(100):316-20. PubMed ID: 15690691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]